INS and Insulin resistance: Although rapamycin treatment did not improve glucose intolerance (Figure 4C), homeostatic model for assessment of insulin resistance (HOMA-IR) values derived from both insulin and glucose levels were significantly reduced (Figure 4D), indicating higher insulin sensitivity which was confirmed by an insulin tolerance test (Figure 4E).